Bioionformality detectable group of novel regulatory oligonucleotides and uses thereof
View Patent ↗The present invention relates to a first group of novel oligonucleotides, here identified as genomic address messenger or GAM oligonucleotides, and a second group of novel operon-like polynucleotides, here identified as genomic record or GR polynucleotides. GAM oligonucleotides selectively inhibit translation of known target genes, many of which are known to be involved in various diseases. Nucleic acid molecules are provided respectively encoding 2147 GAM oligonucleotides, and 313 GR polynucleotides as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM oligonucleotides and GR polynucleotide and specific functions and utilities thereof, for detecting expression of GAM oligonucleotides and GR polynucleotides and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.
1. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 140670 or 140732;
(b) a DNA encoding (a); or
(c) the complement of (a) or (b).
2. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 2 or 9;
(b) a DNA encoding (a);
(c) a sequence at least 80% identical to (a) or (b); or
(d) the complement of any one of (a)-(c).
3. A vector comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of any one of claims 1 and 2 .
4. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of any one of claims 1 and 2 .